The over-expression of NSAID-activated gene (NAG-1) in cancer cells results in growth arrest and an increase in apoptosis, suggesting that NAG-1 has anti-tumorigenic activity acting as a tumor suppressor in the early stages of tumor progression and the expression of NAG-1 can be increased by the COX-II inhibitors. This evidence concerns the gene GDF15 and cancer.